Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues
R Gershon, V Vishnevskia-Dai - PloS one, 2024 - journals.plos.org
Purpose Describing the features of Megalotrichosis (MT) induced by Tyrosine kinase
inhibitors (TKI) and differentiate it from Prostaglandins (PGs)–induced MT. Methods Medical …
inhibitors (TKI) and differentiate it from Prostaglandins (PGs)–induced MT. Methods Medical …
Eyelashes trichomegaly: an unusual side effect of gefitinib therapy
CR Agrawal, P Goyal, DC Doval, K Dutta… - … Journal of Trichology, 2018 - journals.lww.com
Evolution of targeted therapy has changed the spectrum of treatment in oncology since the
past two decades as lots of newer agents are being added to the pharmacologic …
past two decades as lots of newer agents are being added to the pharmacologic …
[PDF][PDF] Molecular Variants in Genes related to the Response to Ocular Hypotensive Drugs in an Afro-Colombian Population
S Silva-Alarcon, C Valencia… - The Open …, 2022 - openophthalmologyjournal.com
Aims: This study aimed to conduct an exploratory analysis of the pharmacogenomic variants
involved in ocular hypotensive drugs to understand the individual differential response in an …
involved in ocular hypotensive drugs to understand the individual differential response in an …
Peptides: A Comparison between Nanoparticles and Mito Organelles to Enhance Eyelash and Eyebrow Growth
G Alvin - Journal of Stem Cells, 2021 - search.proquest.com
Purpose: Peptides have proven to increase the length and thickness of the eyelash and
stimulate the growth of new hair follicles. We evaluated the safety and efficacy of two …
stimulate the growth of new hair follicles. We evaluated the safety and efficacy of two …